NasdaqGS - Delayed Quote USD

Opthea Limited (OPT)

3.4000 -0.2400 (-6.59%)
At close: April 26 at 4:00 PM EDT
3.5000 +0.10 (+2.94%)
After hours: April 26 at 5:06 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
117.0970
108.4060
90.6830
68.6130
59.0610
Cost of Revenue
233.8920
166.8260
160.5010
428.9010
282.0420
Gross Profit
-116.7950
-58.4200
-69.8180
-360.2880
-222.9810
Operating Expense
164,832.2890
149,967.3740
96,468.1450
39,281.6600
16,822.2060
Operating Income
-164,949.0840
-150,025.7940
-96,537.9630
-39,641.9480
-17,045.1870
Net Non Operating Interest Income Expense
-16,562.6860
-10,234.6640
235.4680
372.0010
480.4530
Other Income Expense
10,984.6010
11,813.0230
-2,814.1620
-11,013.3950
-267.2320
Pretax Income
-170,527.1690
-148,447.4350
-99,116.6570
-50,283.3420
-16,831.9660
Tax Provision
-8,919.6690
-5,926.3500
-6,299.2860
-4,938.8460
-5,708.7670
Net Income Common Stockholders
-161,607.5020
-142,521.0850
-92,817.3710
-45,344.4960
-11,123.1990
Diluted NI Available to Com Stockholders
-161,607.5020
-142,521.0850
-92,817.3710
-45,344.4960
-11,123.1990
Basic EPS
-2.41
-2.43
-1.99
-1.07
-0.32
Diluted EPS
-2.41
-2.43
-1.99
-1.07
-0.32
Basic Average Shares
66,548.1440
58,694.6430
46,617.6150
42,490.0590
34,582.0600
Diluted Average Shares
66,548.1440
58,694.6430
46,617.6150
42,490.0590
34,582.0600
Rent Expense Supplemental
--
--
21.3070
18.4450
23.2720
Total Expenses
165,066.1810
150,134.2000
96,628.6460
39,710.5610
17,104.2480
Net Income from Continuing & Discontinued Operation
-161,607.5020
-142,521.0850
-92,817.3710
-45,344.4960
-11,123.1990
Normalized Income
-159,995.1739
-142,051.4754
-90,182.0610
-35,412.8402
-10,946.6020
Interest Income
3,918.0620
3,227.4960
235.4680
372.0010
480.4530
Interest Expense
20,480.7480
13,462.1600
--
--
--
Net Interest Income
-16,562.6860
-10,234.6640
235.4680
372.0010
480.4530
EBIT
-150,046.4210
-134,985.2750
-99,116.6570
-50,283.3420
-17,045.1870
EBITDA
-149,943.4700
-134,884.0480
-99,038.2750
-50,176.6740
-16,948.6500
Reconciled Cost of Revenue
233.8920
166.8250
160.5010
428.9010
282.0410
Reconciled Depreciation
102.9510
101.2270
78.3820
106.6680
96.5370
Net Income from Continuing Operation Net Minority Interest
-161,607.5020
-142,521.0850
-92,817.3710
-45,344.4960
-11,123.1990
Total Unusual Items Excluding Goodwill
-1,701.3180
-489.1370
-2,814.1620
-11,013.3950
-267.2320
Total Unusual Items
-1,701.3180
-489.1370
-2,814.1620
-11,013.3950
-267.2320
Normalized EBITDA
-148,242.1520
-134,394.9110
-96,224.1130
-39,163.2790
-16,681.4180
Tax Rate for Calcs
0.0001
0.0000
0.0001
0.0001
0.0003
Tax Effect of Unusual Items
-88.9899
-19.5274
-178.8520
-1,081.7392
-90.6350
6/30/2020 - 10/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

93Z.F Marinomed Biotech AG
17.45
-0.29%
 
688222.SS HitGen Inc.
12.98
+3.02%
 
PRTC PureTech Health plc
28.50
+2.24%
 
DRMAW Dermata Therapeutics, Inc.
0.0095
+3.26%
 
ELVAF Evolva Holding SA
1.1000
0.00%
 
REGN.VI Regeneron Pharmaceuticals, Inc.
827.00
-0.05%
 
HVO.IR hVIVO plc
0.3200
0.00%
 
BLT.NZ BLIS Technologies Limited
0.0170
0.00%
 
WXIBF WuXi Biologics (Cayman) Inc.
1.6800
+2.13%
 
OCS Oculis Holding AG
12.02
-0.25%